Features

The Pet Health Market: More Humanized Than Ever

As pet owners project their own health concerns onto companion animals, expect to see innovations for longevity, microbiome support, metabolic health, mood/stress, and more.

Research

Synbiotic and Butyrate Formula May Relieve IBS Symptoms: Study

A combination formula by dsm-firmenich featuring a synbiotic and microencapsulated butyrate relieved IBS symptoms significantly, compared to a placebo.

Products & Ingredients

Meala Partners with dsm-firmenich to Commercialize Texturizing Protein for Meat Alternatives

Vertis PB Pea Protein, Meala’s high-performance texturizer, is ready for market release in Europe.

Research

Synbiotic Supplement May Mitigate Post-COVID-19 Chronic Fatigue: Study

Patients with chronic fatigue syndrome appeared to have improved post-exercise malaise and improved brain metabolites following treatment with a synbiotic blend by dsm-firmenich.

Research

Synbiotic Supplement Linked to Digestive Comfort, Behavioral Well-Being in Autistic Children: Study

In 40 children diagnosed with ASD, supplementation was linked to improved gastrointestinal, irritability, and anxiety-related symptoms with or without GDH.

Market Updates

dsm-firmenich Announces Winners of Gut Health Research Grants

The company will be awarding €50,000 to each of five research projects across the Asia-Pacific region.

Products & Ingredients

dsm-firmenich Introduces Dry Vitamin A Form for Early Life Nutrition

The new vitamin A form can overcome stability issues found in traditional vitamin A ingredients, enabling easy incorporation into infant formulas.

Market Updates

Fi Europe Innovation Awards Finalists Announced

The finalists will be awarded across nine categories, across dairy alternatives, manufacturing, food technology, health innovation, and many, many more.

Products & Ingredients

dsm-firmenich Launches Algal DHA Oil with Enhanced Potency

The enhanced potency and improved sensory profile of Life’sDHA B54-0100 can help create more cost-effective capsules and new formats.

Features

Key Trends in Functional Foods for 2025

Brands have runway to build on traditional, familiar ingredients like protein and probiotics to support modern health issues like digestion, mood, sleep, etc.

Market Updates

KD Pharma Group Completes Acquisition of dsm-firmenich’s Marine Lipids Business

The acquisition includes dsm-firmenich’s fish oil business for foods, beverages, supplements, and pharmaceuticals, and the MEG-3 brand and its facilities.

Regulations

dsm-firmenich Secures UK/EU Approvals for Human Milk Oligosaccharides

The two new HMOs are the first assessed by the Food Standards Agency and Food Standards Scotland in post-Brexit UK.

Exclusives

2024 Nutrition Business Mergers & Acquisitions

Despite high interest rates, M&A activity continues. Will rate cuts spur more?

Market Updates

KD Pharma to Acquire dsm-firmenich’s Marine Lipids Business

The transaction includes the MEG-3 fish oil product portfolio and two associated production sites in Canada and Peru.

Products & Ingredients

Nutrileads, dsm-firmenich Plan to Partner on Pet Health Products with Benicaros

Pending the results of studies on dogs and cats involving the precision prebiotic, the two companies will develop a pet food version of the fiber.